Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft: is the flow the best thrombolytic?
- PMID: 20884433
- DOI: 10.4244/EIJ30V6I4A78
Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft: is the flow the best thrombolytic?
Abstract
Aims: Percutaneous coronary intervention (PCI) in the total occlusion of aged saphenous vein grafts (SVGO) is difficult because of inadequate dilatation and distal embolisation. The aim of this study is to report the early experience and clinical outcome of SVGO PCI with a multistaged procedure.
Methods and results: Between January 2003-2006, we treated 20 consecutive patients (pts) admitted with the diagnosis of non-ST segment elevation acute coronary syndromes with culprit lesion located in SVGO. All of them underwent a three stage procedure. Stage 1: recanalisation of graft with undersized balloon; Stage 2: anticoagulation therapy; Stage 3: treatment according to the angiographic result. We obtained vessel recanalisation with TIMI flow 1-2 in 14 pts (70%) by undersized balloon (mean diameter of 1,85±0,43 mm). The mean anticoagulation time was 11±7 days (range 1-20 days). At the Stage 3 all 14 SVG (100%) were patent. A focal lesion was present in 12 pts (86%) treated by stent implantation. In the other two pts (14%) the SVG had no residual lesion. The in-hospital major adverse cardiac event rate was 10%. No death, in-hospital late closure or major bleeding complication occurred. At 2-year follow-up one target vessel revascularisation and one in stent restenosis occurred.
Conclusions: The treatment of SVGO with staged procedure may be used to decrease thrombus burden prior to definitive "short" stent placement and improve the acute and long-term results.
Similar articles
-
Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study.J Interv Cardiol. 2010 Feb;23(1):40-5. doi: 10.1111/j.1540-8183.2009.00525.x. J Interv Cardiol. 2010. PMID: 20465719
-
Contemporary use of embolic protection devices in saphenous vein graft interventions: insights from the stent of saphenous vein grafts trial.Catheter Cardiovasc Interv. 2011 Mar 1;77(4):594. doi: 10.1002/ccd.22821. Catheter Cardiovasc Interv. 2011. PMID: 21351235 No abstract available.
-
Retrograde dilatation of a totally occluded ostial left anterior descending artery from saphenous venous graft in the descending aorta following stenting of the aorto-ostial graft restenosis in a patient with left main coronary artery stenosis.Catheter Cardiovasc Interv. 2003 Jul;59(3):357-60. doi: 10.1002/ccd.10530. Catheter Cardiovasc Interv. 2003. PMID: 12822159
-
Embolic protection devices in saphenous percutaneous intervention.EuroIntervention. 2009 May;5 Suppl D:D45-50. EuroIntervention. 2009. PMID: 19736070 Review.
-
Embolic protection devices in saphenous vein graft interventions.J Interv Cardiol. 2006 Dec;19(6):525-9. doi: 10.1111/j.1540-8183.2006.00204.x. J Interv Cardiol. 2006. PMID: 17107367 Review.
Cited by
-
Saphenous vein graft interventions.Curr Treat Options Cardiovasc Med. 2014 May;16(5):301. doi: 10.1007/s11936-014-0301-x. Curr Treat Options Cardiovasc Med. 2014. PMID: 24643432
-
Secondary revascularization after CABG surgery.Nat Rev Cardiol. 2012 Sep;9(9):540-9. doi: 10.1038/nrcardio.2012.100. Epub 2012 Jul 10. Nat Rev Cardiol. 2012. PMID: 22776987 Review.
MeSH terms
LinkOut - more resources
Medical
Miscellaneous